Találati lista | Tudóstér

001-es BibID:	BIBFORM095042
035-os BibID:	(WoS)000755462300001 (Scopus)85142845979
Első szerző:	Blöndal, Mai
Cím:	Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway and Sweden according to national ongoing registries / Mai Blöndal, Tiia Ainla, Jaan Eha, Piret Lõiveke, Toomas Marandi, Aet Saar, Gudrun Veldre, Robert Edfors, Christian Lewinter, Tomas Jernberg, Jarle Jortveit, Sigrun Halvorsen, Dávid Becker, Zoltán Csanádi, Tamas Ferenci, Péter Andréka, András Jánosi
Dátum:	2022
ISSN:	2058-5225 2058-1742
Megjegyzések:	Aims Describe the characteristics, management and outcomes of hospitalized ST-segment elevation myocardial infarction (STEMI) patients according to national ongoing myocardial infarction registries in Estonia, Hungary, Norway, and Sweden. Methods and results Country-level aggregated data was used to study baseline characteristics, use of in-hospital procedures, medications at discharge, in-hospital complications, 30-day and 1-year mortality for all patients admitted with STEMI during 2014-2017 using data from EMIR (Estonia; n = 4584), HUMIR (Hungary; n = 23 685), NORMI (Norway; n = 12 414, data for 2013?2016), and SWEDEHEART (Sweden; n = 23 342). Estonia and Hungary had a higher proportion of women, patients with hypertension, diabetes, and peripheral artery disease compared to Norway and Sweden. Rates of reperfusion varied from 75.7% in Estonia to 84.0% in Sweden. Rates of recommendation of discharge medications were generally high and similar. However, Estonia demonstrated the lowest rates of dual antiplatelet therapy (78.1%) and statins (86.5%). Norway had the lowest rates of beta-blockers (80.5%) and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (61.5%). The 30-day mortality rates ranged between 9.9% and 13.4% remaining lowest in Sweden. One-year mortality rates ranged from 14.8% in Sweden and 16.0% in Norway to 20.6% in Hungary and 21.1% in Estonia. Age-adjusted lethality rates were highest for Hungary and lowest for Sweden. Conclusion This inter-country comparison of data from four national ongoing European registries provides new insights into the risk factors, management and outcomes of patients with STEMI. There are several possible reasons for the findings, including coverage of the registries and variability of baseline-characteristics' definitions that need to be further explored.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk ST-segment elevation myocardial infarction Registry study Real-world evidence Mortality
Megjelenés:	European Heart Journal - Quality of Care and Clinical Outcomes. - 8 : 3 (2022), p. 307-314. -
További szerzők:	Ainla, Tiia Eha, Jaan Lõiveke, Piret Marandi, Toomas Saar, Aet Veldre, Gudrun Edfors, Robert Lewinter, Christian Jernberg, Tomas Jortveit, Jarle Halvorsen, Sigrun Becker Dávid Csanádi Zoltán (1960-) (kardiológus) Ferenci Tamás Andréka Péter Jánosi András
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: